|Articles|November 1, 2011

Improving Clinical Operations with Digital Signatures

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe

Related Content

What Success Looks Like for CROs Building Infrastructure Around Program-Level Recruitment

ByGaynor Anders,Andy Studna, Senior Editor

July 15th 2026

ACT Brief: Organizational Barriers to Programmatic Recruitment, Scaling Selective Safety Data Collection, and Subcutaneous Alzheimer's Treatment

ByAndy Studna, Senior Editor

July 15th 2026

Selective Safety Data Collection and the Case for Simpler Trials: Q&A with Rob DiCicco, TransCelerate Biopharma

ByRob DiCicco,Andy Studna, Senior Editor

July 14th 2026

The Biggest Adoption Challenges in Moving to Portfolio-Level Recruitment

ByGaynor Anders,Andy Studna, Senior Editor

July 14th 2026

ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy

ByAndy Studna, Senior Editor

July 14th 2026

Improving Clinical Operations with Digital Signatures

Related Content

What Success Looks Like for CROs Building Infrastructure Around Program-Level Recruitment

ACT Brief: Organizational Barriers to Programmatic Recruitment, Scaling Selective Safety Data Collection, and Subcutaneous Alzheimer's Treatment

Selective Safety Data Collection and the Case for Simpler Trials: Q&A with Rob DiCicco, TransCelerate Biopharma

The Biggest Adoption Challenges in Moving to Portfolio-Level Recruitment

ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy

Trending on Applied Clinical Trials Online

ACT Brief: Portfolio-Level Recruitment Strategy, Real-Time Burden Sampling, and Platinum-Free Bladder Cancer Therapy

Selective Safety Data Collection and the Case for Simpler Trials: Q&A with Rob DiCicco, TransCelerate Biopharma

FDA Pauses Real-Time Release of Drug Rejection Letters While Working to Formalize Policy

ACT Brief: FDA CRL Transparency Pause, Protocol-Centric Recruitment Model Shift, and Medical Affairs Integration in Development

Before Burden Becomes Risk: Capturing Friction in Real Time